Instrumentation Laboratory upcoming IVD launches to include Synthesis critical care analyzer.
This article was originally published in The Gray Sheet
Executive Summary
INSTRUMENTATION LABORATORY IVD PRODUCT LINE EXTENSIONS in critical care, hemostasis and clinical chemistry in vitro diagnostics are slated for introduction in the next 12 months, the firm says in a prospectus for its recently completed initial public offering of 5.4 mil. American Depositary Shares ("The Gray Sheet" Nov. 11, p. 25). The new products are a "key element" of the Milan, Italy-based firm's strategy to build on core strengths and "capitalize on opportunities for growth and profitability," the firm states.